Tuesday, December 3, 2024
12/3/2024
PROJECT SUMMARY/ABSTRACT The goal of the annual Jackson Laboratory Short Course on Experimental Models of Human Cancer is to train graduate students, postdocs, and junior investigators in the basic science and application of experimental models of human cancer. The training program will immerse participants and faculty in a unique and highly integrated scientific environment and empower the next generation of scientists tackling human cancer. The integrated program will cover advances in three critical areas: experimental cancer models, modern technology to assess mechanisms and outcomes, and the interplay of the tumor and host genetics as well as tumor microenvironment and the immune system. It will teach classical approaches to mouse and human genetics, modern molecular genetic methodologies, computational and bioinformatics concepts, ontological standards, and scientific and medical ethics. Trainees will participate in lectures, workshops, multi-disciplinary scientific debates, networking and career development sessions, and poster sessions. They will receive practical training in bioinformatics, statistical genetics, and the use and analysis of PDX models. This course will take place at The Jackson Laboratory (JAX), which hosts an NCI-designated Basic Laboratory Cancer Center and is a global resource of mouse models. The proposed 8-day intensive, immersion course focused on graduate students, postdocs, and new investigators will promote active interaction and networking between the participants as well as with the outstanding cadre of lecturers and trainers. Additionally, the Short Course will be delivered in a hybrid format, with online/virtual access to the seminars and, where practical and feasible, the workshops: this was successfully piloted in 2022. The hybrid format enhances inclusivity by reducing barriers to participation for individuals who could not otherwise attend. JAX is deeply committed to training a diverse group of biomedical scientists and we will continue to promote diversity in both the recruitment of participants and in the tools being generated to study cancer. Diverse attendees will be actively recruited, scholarships will be provided to enable in-person attendance, and an inclusive virtual option will enable participation by those that are unable to travel. Diversity will also be emphasized in the context of best practices for cancer research to address ongoing health care disparities, the need for studies of genetically diverse models, and representation of diverse backgrounds within genetic databases and samples.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
